Related Experiment Video
Updated: May 4, 2026

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
Published on: January 10, 2025
Clinical marker of platelet hyperreactivity in diabetes mellitus
Jin Hwa Kim1, Hak Yeon Bae1, Sang Yong Kim1
1Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea.
Insights
Diabetic patients face higher risks of atherothrombotic events due to altered platelet function. Understanding these platelet abnormalities is key for managing diabetes complications and predicting cardiovascular events.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Hematology
Background:
- Diabetes mellitus is a significant risk factor for atherothrombotic complications, contributing to morbidity and mortality.
- Diabetes is characterized by a prothrombotic state, involving increased coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity.
- Altered platelet function is a critical factor in the prothrombotic status observed in diabetic patients.
Purpose of the Study:
- To review the current understanding of platelet function abnormalities in diabetes.
- To highlight the role of platelet hyperreactivity in diabetic atherothrombosis.
- To discuss clinical markers associated with platelet hyperreactivity in diabetes.
Main Methods:
- Literature review of studies on platelet function in diabetes.
- Analysis of factors contributing to the prothrombotic state in diabetic patients.
- Examination of clinical markers of platelet hyperreactivity.
Main Results:
- Diabetes is associated with significant alterations in platelet function.
- Platelet hyperreactivity is a key contributor to atherothrombotic events in diabetes.
- Specific clinical markers reflect platelet hyperreactivity in diabetic individuals.
Conclusions:
- Understanding platelet function abnormalities is crucial for managing diabetes-related cardiovascular risks.
- Focusing on platelet function can improve the prediction and prevention of atherothrombotic events in diabetic patients.
- Further research into platelet behavior in diabetes is warranted for therapeutic advancements.
Abstract:
Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

